NCT03086681 2025-07-29
ECWHCCFLACC
First Affiliated Hospital of Guangxi Medical University
Phase 2 Completed
Clinical Trials
12 trialsNCT02350517 2023-02-16
Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal Cancer
Sun Yat-sen University
Phase 2 Completed
NCT03121833 2019-12-26
Endostar Combined With Chemotherapy for Stage â…£ Soft Tissue Sarcoma
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Completed
NCT00004872 2019-12-13
Endostatin in Treating Patients With Advanced Refractory Solid Tumors
University of Wisconsin, Madison
Phase 1 Completed
NCT01733589 2017-07-14
Recombinant Human Endostatin Continued Pumping Into Vein Combining With CCRT in Unresectable Stage III NSCLC
Zhejiang Cancer Hospital
Phase 1/2 Completed
NCT03117335 2017-04-17
Recombinant Endostatin Combined With Vinorelbine and Cisplatin in Patients With Advanced Non-small Cell Lung Cancer
Jiangsu Wuzhong Pharmaceutical Group Co., Ltd.
Phase 3 Completed
NCT01845675 2017-04-13
Chemotherapy Plus Endostatin in Advanced Pancreatic Neuroendocrine Tumor
Peking Union Medical College Hospital
Phase 2 Completed
NCT02104323 2017-02-09
Endostatin
Beijing Tiantan Hospital
Phase 2 Completed
NCT02497118 2015-07-14
Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage â…¢A NSCLC
Tianjin Medical University Cancer Institute and Hospital
Phase 4 Completed
NCT00004229 2013-02-11
Endostatin in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT01124253 2010-05-17
Dengshan
Shanghai Jiao Tong University School of Medicine
Phase 3 Completed
NCT00604435 2010-01-20
Neoadjuvant Endostatin and Chemotherapy for Breast Cancer
Xijing Hospital
Phase 2 Completed